{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:37:46Z","timestamp":1758055066141,"version":"3.44.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.chest.2017.07.040","type":"journal-article","created":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T04:48:28Z","timestamp":1513658908000},"page":"914-916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The St. George\u2019s Respiratory Questionnaire Appendix to the Food and Drug Administration Draft Guidance on COPD"],"prefix":"10.1016","volume":"152","author":[{"given":"Stephen I.","family":"Rennard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora","family":"Merrill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Tal-Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank C.","family":"Sciurba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chest.2017.07.040_bib1","unstructured":"Food and Drug Administration. Innovation\/stagnation: challenge and opportunity on the critical path to new medicinal products. 2004. http:\/\/www.fda.gov\/downloads\/scienceresearch\/specialtopics\/criticalpathinitiative\/criticalpathopportunitiesreports\/ucm113411.pdf. Accessed February 1, 2017."},{"issue":"3","key":"10.1016\/j.chest.2017.07.040_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/15412555.2012.752807","article-title":"The COPD Biomarker Qualification Consortium (CBQC)","volume":"10","author":"Casaburi","year":"2013","journal-title":"COPD"},{"issue":"98","key":"10.1016\/j.chest.2017.07.040_bib3","first-page":"31946","article-title":"Chronic obstructive pulmonary disease: developing drugs for treatment; draft guidance for industry","volume":"81","year":"2016","journal-title":"Fed Regist"},{"issue":"5","key":"10.1016\/j.chest.2017.07.040_bib4","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1183\/09031936.00004814","article-title":"The PROactive innovative conceptual framework on physical activity","volume":"44","author":"Dobbels","year":"2014","journal-title":"Eur Respirat J"},{"issue":"2","key":"10.1016\/j.chest.2017.07.040_bib5","first-page":"109","article-title":"The COPD Biomarkers Qualification Consortium St George\u2019s Respiratory Questionnaire manuscripts: output of a consortium to advance drug development","volume":"4","author":"Tabberer","year":"2017","journal-title":"Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.chest.2017.07.040_bib6","unstructured":"Sullivan T. Senators send FDA letter with concerns over draft guidance documents. Policy and Medicine website. http:\/\/www.policymed.com\/2016\/06\/senators-send-fda-letter-with-concerns-over-draft-guidance-documents.html."}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369217326909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369217326909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:36:19Z","timestamp":1757921779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369217326909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0012369217326909"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2017.07.040","relation":{},"ISSN":["0012-3692"],"issn-type":[{"type":"print","value":"0012-3692"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The St. George\u2019s Respiratory Questionnaire Appendix to the Food and Drug Administration Draft Guidance on COPD","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2017.07.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}